Barrier function of the gut and multiple organ dysfunction after cardiac surgery

Journal of International Medical Research

Volumn 35, Issue 1, 2007, Pages 72-83

  Braun, Jan P ^a   Buhner, S ^a   Kastrup, M ^a   Dietz, E ^a   Langer, K ^a   Dohmen, P M ^a   Lochs, H ^a   Spies, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Gastrointestinal barrier function; Multiple organ dysfunction

Indexed keywords

ENDOTOXIN ANTIBODY; LACTULOSE; MANNITOL; SUCRALOSE; SUCROSE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTENSIVE CARE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROGNOSIS; URINALYSIS;

EID: 33947601839     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000703500107     Document Type: Article

References (35)

1. Fink MP: Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care 2003; 9: 143-151.
2. Deitch EA: Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 2001; 7: 92-98.
3. Chieveley-Williams S, Hamilton-Davies C: The role of the gut in major surgical post-operative morbidity. Int Anesthesiol Clin 1999; 37: 81-110.
4. Davies SJ, Wilson RJ: Preoperative optimization of the high-risk surgical patient. Br J Anaesth 2004; 93: 121-128.
5. Sun Z, Wang X, Andersson R: Role of intestinal permeability in monitoring mucosal barrier function. Dig Surg 1998; 15: 386-397.
6. Meddings JB, Sutherland LR, Byles NI, Wallace JL: Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993; 104: 1619-1626.
7. Wyatt J, Vogelsang H, Hübl W, Waldhoer T, Lochs H: Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341: 1437-1439.
8. Anderson AD, Jain PK, Fleming S, Poon P, Mitchell CJ, MacFie J: Evaluation of the triple sugar test of colonic permeability in humans. Acta Physiol Scand 2004; 182: 171-177.
9. Suenaert P, Bulteel V, Den Hond E, Geypens B, Monsuur F, Luypaerts A, et al: In vivo influence of nicotine on human basal and NSAID-induced gut barrier function. Scand J Gastroenterol 2003; 38: 399-408.
10. Bennett-Guerrero E, Barclay GR, Weng PL, Bodian CA, Feierman DE, Vela-Cantos F, et al: Endotoxin-neutralizing capacity of serum from cardiac surgical patients. J Cardiothorac Vasc Anesth 2001; 15: 451-454.
11. Mythen MG, Barclay GR, Purdy G, Hamilton-Davies C, Mackie IJ, Webb AR, et al: The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ dysfunction. Blood Coagul Fibrinolysis 1993; 4: 999-1005.
12. Bennett-Guerrero E, Panah MH, Barclay GR, Bodian CA, Winfree WJ, Andres LA, et al: Decreased endotoxin immunity is associated with greater mortality and/or prolonged hospitalization after surgery. Anesthesiology 2001; 94: 992-998.
13. Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, White WD, Barclay GR, Smith PK, et al: Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 1997; 277: 646-650.
14. Hamilton-Davies C, Barclay GR, Cardigan RA, McDonald SJ, Purdy G, Machin SJ, et al: Relationship between preoperative endotoxin immune status, gut perfusion, and outcome from cardiac valve replacement surgery. Chest 1997; 112: 1189-1196.
15. Penalva JC, Martinez J, Laveda R, Esteban A, Munoz C, Saez J, et al: A study of intestinal permeability in relation to the inflammatory response and plasma endocab IgM levels in patients with acute pancreatitis. J Clin Gastroenterol 2004; 38: 512-517.
16. Braun JP, Grosse J, Doepfmer U, von Heymann C: Standards in der Herzchirurgie. In: Check-up Anästhesiologie, 2nd edn (Kox W, Spies C, eds). Heidelberg: Springer, 2005; pp95-133.
17. Saltzman JR, Kowdley KV, Perrone G, Russell RM: Changes in small-intestine permeability with aging. J Am Geriatr Soc 1995; 43: 160-164.
18. Nathavitharana KA, Lloyd DR, Raafat F, Brown GA, McNeish AS: Urinary mannitol: lactulose excretion ratios and jejunal mucosal structure. Arch Dis Child 1988; 63: 1054-1059.
19. Johnston SD, Smye M, Watson RP: Intestinal permeability in celiac disease. Clin Lab 2001; 47: 143-150.
20. Sigalet DL, Martin GR, Poole A: Differential sugar absorption as a marker for adaptation in short bowel syndrome. J Pediatr Surg 2000; 35: 661-664.
21. Farhadi A, Keshavarzian A, Holmes EW, Fields J, Zhang L, Banan A: Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 784: 145-154.
22. Le Gall JR, Loirat P, Alperovitch A: APACHE II: a severity of disease classification system. Crit Care Med 1986; 14: 754-755.
23. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963.
24. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al: Use of the SOFA score to assess the incidence of organ dysfunction/ failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793-1800.
25. Miranda DR, de Rijk A, Schnaufeli W: Simplified Therapeutic Intervention Scoring System: the TISS-28 items - results from a multicenter study. Crit Care Med 1996; 24: 64-73.
26. Brunner E, Domhof S, Langer F: Non-parametric Analysis of Longitudinal Data in Factorial Experiments. New York: John Wiley & Sons, 2002.
27. Hein OV, Birnbaum J, Wernecke K, Konertz W, Spies C: Prolonged intensive care unit stay in cardiac surgery: risk factors and long-term-survival. Ann Thorac Surg 2006; 81: 880-885.
28. Smecuol E, Bai JC, Sugai E, Vazquez H, Niveloni S, Pedreira S, et al: Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 2001; 49: 650-655.
29. O'Dwyer ST, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW: A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988; 123: 1459-1464.
30. Wicks C, Somasundaram S, Bjarnason I, Menzies IS, Routley D, Potter D, et al: Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet 1994; 344: 837-840.
31. Kanwar S, Windsor AC, Welsh F, Barclay GR, Guillou PJ, Reynolds JV: Lack of correlation between failure of gut barrier function and septic complications after major upper gastrointestinal surgery. Ann Surg 2000; 231: 88-95.
32. Braun JP, Schroeder T, Buehner S, Dohmen P, Moshirzadeh M, Grosse J, et al: Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass. Acta Anaesthesiol Scand 2004; 48: 697-703.
33. Strutz F, Heller G, Krasemann K, Krone B, Muller GA: Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med 1999; 25: 435-444.
34. Pape HC, Remmers D, Grotz M, Schedel I, von Glinski S, Oberbeck R, et al: Levels of antibodies to endotoxin and cytokine release in patients with severe trauma: does posttraumatic dysergy contribute to organ failure? J Trauma 1999; 46: 907-913.
35. Rothenburger M, Soeparwata R, Deng MC, Schmid C, Berendes E, Tjan TD, et al: Prediction of clinical outcome after cardiac surgery: the role of cytokines, endotoxin, and anti-endotoxin core antibodies. Shock 2001; 16 (Suppl 1): 44-50.